Exciton Technologies receives FDA approval to market exSALT(TM)

... technology utilizing silver oxysalts as the active ingredient. "This achievement represents a ... larger market by: - Utilizing a more active form of silver; - Reducing costs; and - ... deposition technique to form a coating of active species of silver on a wide range of materials. ...

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia

... of Gram-positive organisms; radezolid is also active against linezolid-resistant isolates. ... is developing novel classes of antibiotics active against multi-drug resistant Gram-negative ... is focused on developing an IV/oral macrolide active against methicillin-resistant S. aureus , ...

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

... orBec((R) )is a highly potent, topically active corticosteroid that has a local effect on inflamed tissue. BDP, the active component of orBec((R)), has been marketed in the ... States and worldwide since the early 1970s as the active pharmaceutical ingredient in inhalation products ...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

... sublingual low dose formulation of zolpidem, the active agent most commonly prescribed in the United ... one-quarter to one-third of the dose of active drug contained in currently marketed ... seen in these trials was headache (2.7 percent active versus 1.4 percent placebo in the outpatient ...

Sanofi-aventis Announces Second Quarter 2009 Results

... 2008, when the figures were boosted by sales of active ingredient to our Japanese partners. First-half ... countries, irbesartan is not protected by an active ingredient patent. In the main European countries, Aprovel((R)) is protected by an active ingredient patent through August 2012. Net sales ...

Regado Biosciences Expands Medical Advisory Board

... of antithrombotic therapeutic aptamers with active control agents, today announced the expansion of ... field of antithrombotic aptamers with specific, active control agents. Our Medical Advisory Board ... by its specific and complementary oligonucleotide active control agent. This technology is being applied ...

Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply

... vaccine, a pediatric combination vaccine for active immunization against five serious childhood ... Vaccine Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, ... Vaccine ActHIB vaccine is indicated for the active immunization of infants and children 2 through 18 ...

Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus

... standard of care in patients with serologically active systemic lupus erythematosus (SLE). The ... by the sustained improvement in serologically active SLE patients treated with belimumab through four ... frequency of SLE disease flares in serologically active patients through four years of treatment. The ...

Frost & Sullivan Recognizes Cisbio Bioassays for Technology Innovation

... the context of crystallization. The other, very active area of scientific pursuit has remained the ... the substrates come in contact with the enzyme active site," observes Dr. Basu. "Hence, non-specific ... in Louvain-la-Neuve, Belgium, IBA is primarily active in the medical industry. It develops and markets ...

Regado Biosciences Establishes Medical Advisory Board

... of antithrombotic therapeutic aptamers with active control agents, today announced the establishment ... by its specific and complementary oligonucleotide active control agent. This technology is being applied ... (RB006) and the second being its complementary active control agent (RB007). RB007 can be used to ...

Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients

... in adult patients with moderate to severe active disease who have had an inadequate response to ... treatment of adults with moderately to severely active rheumatoid arthritis. Cimzia(R) was approved in ... clinical response and remission in patients with active Crohn's disease who have not responded adequately ...

Baseline Research Indicates High Interest in Centocor-Ortho Biotech's SIMPONI(R)

... for the treatment of moderately to severely active rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis. The product will be ...

Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

... is Relevance active against ... is developing novel classes of antibiotics active against multi-drug resistant Gram-negative ... is focused on developing an IV/oral macrolide active against methicillin-resistant S. aureus , ...

ChartTrends(R): Bone and Mineral Metabolism in Dialysis Reveals Latest Trends in the Treatment of Calcium, Phosphorus and PTH

... with phosphate binders, Nutritional Vitamin D, active Vitamin D and Sensipar. Moreover, it provides ... The vast majority of dialysis patients are on active Vitamin D formulations such as Abbott's Zemplar ... Vitamin D does have an impact on the dose of active Vitamin D. Although the use ...

Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver

... prodrug designed to enhance the formation of its active triphosphate in the liver, while minimizing ... nucleoside metabolite (NM). IDX184 is fully active against HCV genotypes 1, 2, 3 and 4 and, ... nucleoside metabolite were similar to that of its active triphosphate measured in vitro in human ...

Hovione Opens its New API Plant in Cork

... held today the opening ceremony of its new active pharmaceutical ingredient manufacturing site ... and the Cork site will be used to produce active pharmaceutical ingredients (APIs) for a large ... company with 50 years' experience in active Pharmaceutical Ingredient development and ...

PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

... Improvement in Overall Survival - - First active Immunotherapy for Cancer to Prolong Survival - ... and may represent the first in a new class of active cellular immunotherapies specifically designed to ... may represent the first product in a new class of active cellular immunotherapies (ACIs). PROVENGE and ...

Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

... for the treatment of moderately to severely active rheumatoid arthritis (RA), active psoriatic arthritis (PsA) and active ankylosing spondylitis (AS). With this approval ...

Marinus Pharmaceuticals Raises $20 Million in Series B Financing

... companies. For 20 years, they have taken an active and committed role in the companies in which they ... and WebLoyalty. Other Canaan investments include active Networks, AdvancedBioHealing, BharatMatrimony, ... medicine technology sectors. Foundation is an active venture investor, providing leadership, support, ...

A molecular ripcord for chemical reactions

... a catalyst can be switched from a dormant to an active state (see illustration) by pulling on a polymer ... link The researchers packed a catalytically active metal ion completely in using two molecular caps ... The cap on one end was now broken off from the active metal ion, which allowed the metal ion to become ...

BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth

... product based on probiotic microorganisms active ingredient easily integrated into consumer ... (scientific name: Lactobacillus) , the active ingredient in pro-t-action(TM) binds to and ... a proprietary production process enabling the active ingredient to be easily integrated into everyday ...

Publication of Shire plc's Annual Report 2008

... Group dual-sources certain key products and/or active ingredients. However, the Group currently relies ... REMINYL and XAGRID and relies on a single active ingredient source for each of ELAPRASE, FIRAZYR, ... products depends on the ability to procure active ingredients and special packaging materials ...

CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas

... ROBODOC(R) will display its accuracy through active demonstrations of hip and knee* replacement ... in Las Vegas where we will present the only active robotic system cleared by the FDA for orthopaedic ... Hip Arthroplasty procedures; making it the only active robotic system cleared by the FDA for orthopaedic ...

SENOMYX ANNOUNCES FOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS

... food and beverage products. Samples that are active in the screening assay are being scaled up and ... (table salt) and potassium chloride that are active in the assays. These enhancers, which represent ... has initiated taste tests of samples that were active in the Company's proprietary high-throughput ...

Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing

... "Delafloxacin proved to be the more active compound compared to tigecycline when evaluated ... next-generation fluoroquinolone, that is more active than other quinolones against Gram-positive ... is developing novel classes of antibiotics active against multi-drug resistant Gram-negative ...

China-Biotics, Inc. Receives Manufacturing Certificate for New Products

... to consumers. Synbiotics Capsules' primary active ingredients are lactobacillus thermophilus, ... health. Probiotics Gegen Capsules' primary active ingredients are lactobacillus acidophilus and ... Tremella Polysaccharide Capsules' primary active ingredients are LA-BB and tremella ...

Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes

... to have an aesthetic benefit, bimatoprost, the active ingredient in LATISSE(TM), was first approved in ... favorable safety profile. Bimatoprost is the active pharmaceutical ingredient in the formulation of ... III study, 278 healthy adult patients with no active ocular disease and with baseline minimal or ...

Organic, Preservative-Free Skin Care Products from Dermaheal Now Available in the United States

... lies in its scientific foundation. The product's active ingredients are proprietary peptides proven to ... delivery system of nanotechnology, the active peptides are embedded within tiny capsules called ... shown that over time the optimum efficacy of the active ingredients in any skin care product drops ...

New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease

... in adult patients with moderate to severe active disease who have had an inadequate response to ... in adult patients with moderate to severe active disease who have had an inadequate response to ... TNF blockers such as CIMZIA (R) . However, active tuberculosis has developed in patients receiving ...

DuPont Launches Innovative Renewably Sourced Material for Carpet Cushion

... carpet cushioning technology, DuPont's™ active Layer RS moisture barrier film is laminated to ... today announced it has introduced DuPont™ active Layer RS renewably sourced moisture barrier ... carpet cushioning technology, DuPont™ active Layer RS moisture barrier film is laminated to ...

ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments

... technology. The Dermocapsule™ encapsulates active ingredients and protects them from damaging ... to the skin. They deliver an even application of active substances to minimize irritation, and active ingredients penetrate deeper for better skin ...

Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results

... million. "Fiscal 2008 was extremely active for the Company," said Glenn L. Cooper, M.D., ... product. "Our R&D group is also quite active as we begin late stage clinical trials for two ... bladder removal. "Fiscal 2008 was also an active and successful year for our Business Development ...

Dendreon Reports Third Quarter 2008 Financial Results

... safety and efficacy of the investigational active cellular immunotherapy PROVENGE(R) (sipuleucel-T) ... Phase 2 trial of PROVENGE called ProACT (PROstate active Cellular Therapy) or P07-2. The ... single-center trial called NeoACT (NEOadjuvant active Cellular immunoTherapy), or P07-1, which is ...

SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS

... food and beverage products. Samples that are active in the screening assay are being scaled up in ... sodium chloride (table salt) enhancers that are active in the assays is a significant step forward. In ... unwanted taste effects. Enhancers that were active in the assays are being optimized and scaled ...

Therapure Biopharma Inc. announces collaboration with BioVectra Inc.

... Biopharma. "They bring significant expertise in active pharmaceutical ingredient development and a high ... contract manufacturing and product development of active pharmaceutical ingredients, pharmaceutical ... holds 8 Drug Master File filings and is an active supplier to most of the major ...

Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis

... placebo- controlled studies in patients with active moderate to severe rheumatoid arthritis (RA) were ... and the second study was in patients who were active despite ongoing treatment with methotrexate. ... of golimumab were studied in patients who had active RA and who were previously treated with anti-TNF ...

One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study

... in the joint and skin symptoms of active psoriatic arthritis through six months with ... with at least three swollen and tender joints and active psoriatic skin lesions of at least 2 centimeters ... At week 24 all placebo patients crossed over to active treatment with golimumab 50 mg. The ...

Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA

... from cSSSI and CAP. Ceftaroline was highly active against over 1,500 gram-positive pathogens ... it was found to be highly active against more than 500 community-acquired ... than ceftriaxone. Ceftaroline was eight-fold more active than ceftriaxone and four-fold ...

Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium

... active metabolite concentrations of NKTR-102 ... of 2008. The observed plasma half life of the active metabolite (SN38) of NKTR-102 was 50 days; this ... irinotecan dosing.(1) Increased SN38 levels, the active metabolite of irinotecan responsible for its ...

Derma Sciences Announces Multiple Clinical Posters Featuring MEDIHONEY(R) and ALGICELL Ag(R) to be Presented at Upcoming Wound Care Conference

... featured include MEDIHONEY dressing with active Leptospermum Honey, ALGICELL Ag Silver ... products include: "Limb at Risk: Use of active Leptospermum Honey for the management of an ... PA "Management of an MRSA colonized wound using active Leptospermum Honey impregnated calcium alginate." ...